跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Almefen
Approved
STANDARD
Almefen
Lloyd Laboratories,Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0a516cf373f356e7
Company
Lloyd Laboratories,Inc.
Type
Standard
Approval Details
Approval Id
0a516cf373f356e7
Drug Approval Philippines Name
Almefen
Product Name
Almefen
Registration Number
DRP-1304-03
Brand Name
Almefen
Generic Name
Mefenamic Acid
Dosage Form
Capsule
Dosage Strength
500 mg
Manufacturer
Lloyd Laboratories,Inc.
Trader
Interhealthcare Pharmaceuticals, Inc.
Distributor
ALTOMED PHARMACEUTICALS INC.
Issuance Date
30 January 2022
Expiry Date
28 February 2027
Pharmacologic Category
Non-steroidal Anti-inflammatory Agent (Non-selective COX Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0a516cf373f356e7
Type
Standard
Back to Philippines FDA Approvals
Almefen - Philippines FDA Drug Approval Details